Pasithea Therapeutics Corp. · NASDAQ:KTTA
Armistice Capital, LLC reported a 9.99% stake in Pasithea Therapeutics Corp. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Armistice Capital, LLC reported a 9.99% stake in Pasithea Therapeutics Corp., 133,787 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 133,787
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 9.99% | 133,787 |
| Steven Boyd | 9.99% | 133,787 |
Source
Related
- Pasithea Therapeutics Corp.
- Armistice Capital, LLC
- Pasithea Therapeutics Corp. shareholders
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2025
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G/A · Opaleye Management Inc. · Jul 31, 2026
- Schedule 13G/A · Coastlands Capital LP · Jul 1, 2026
- Schedule 13G · Stonepine Capital Management, LLC · Jun 23, 2026
- Form 4 · Coastlands Capital LP · Jun 22, 2026